Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
1.2 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
European Society of Endocrinology (ESE)
EU Transparency Register
270225149770-57 First registered on 11 Apr 2023
Goals / Remit
The European Society of Endocrinology is at the centre of Europe's endocrine community. It is our vision to shape the future of endocrinology to improve science, knowledge and health. It is our mission to advance endocrinology. We unite, support and represent our specialty, promoting collaboration and best practice, and enable our community to develop and share the best knowledge in endocrine science and medicine.
Through the 46 National Societies involved with the ESE Council of Affiliated Societies (ECAS) ESE represents a community of over 22,000 European endocrinologists. We work together with other European Societies that are focussed on sub-segments of endocrine disease and health, and which are focussed on prevalent as well as rare endocrine disorders.
We inform policy makers on health and research policy decisions through advocacy efforts across Europe. We also create awareness about what each individual can do to lead a healthy hormonal life.Main EU files targeted
• Classification Labelling and Packaging regulation (CLP).
• Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation (REACH).
• Chemicals Strategy for Sustainability.
• European Beating Cancer Plan.
• European Health Data Space (EHDS).
• In Vitro Diagnostic Medical Devices Regulation (IVDR).Address
Head Office
Redwood HouseBrotherswood Court, Great Park Road
Bristol BS32 4QW
UNITED KINGDOMEU Office
Redwood HouseBrotherswood Court, Great Park Road
Bristol BS32 4QW
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
4
Employment time Lobbyists 50% 2 10% 2 Lobbyists (Full time equivalent)
1.2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 15 Jan 2025
Name Start date End Date Michael VAN EIMEREN 26 May 2023 25 May 2024 Mr Mischa van Eimeren 26 May 2023 30 May 2023 Complementary Information
These numbers represent ESE staff-employees. Beyond these specific staff ESE has created internal structures to develop its policy and advocacy approach. These structures build on the voluntary engagement of clinical and basic research experts associated with leading endocrine academic centers around Europe. These experts are engaged in different committees of the organisation (Executive Committee, Policy and Advocacy Taskforce and working groups, European Council of Affiliated Societies).
Nothing of the compensation of the ESE staff is dependent on funding provided by a third party.Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
The European Society of Endocrinology is member of
1. The Alliance for Biomedical Research in Europe (Biomed Alliance): https://www.biomedeurope.org/
2. The European Cancer Organisation: https://www.europeancancer.org/
The European Society of Endocrinology is associated to other Endocrine societies around the world. These organizations can be found at https://www.ese-hormones.org/membership/organisational-memberships/associate-partner-societies/Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
4,070,336€
Major funding types in closed year
Member's contributions, Grants, Other
Funding types "other" information
The ESE society income consists of the following area's: 1. Membership contributions (individual and society and corporate memberships) 2. Member registration fees for congress and educational events 3. Sponsorships from Corporate Members 4. Educational grant support provided by third parties -corporate members 5. Income from ESE publishing activities
Major contributions in closed year
None declared
Other financial info
None of the contributions received from corporate or other members, and or entities sponsoring the society exceeded 10% of the total income of ESE (i.e. 407 034 €) Within the income received from corporate members (total of € 1,376,393) the following companies contributed with more than € 10 000 and represented more than 10% of the total sponsors income:
HRA Pharma Rare Diseases: € 226,844 or 16,48%
Recordati Rare Diseases AG: € 169,225 or 12.29 %
Pfizer Ltd: € 166,310 or 12.08 %
Ascendis Pharma: € 155,530 or 11.30 %
ESE provides full transparency eg towards the European Medicine Agency.
In 2023, ESE contracted with Hill+Knowlton Strategies (H+K), Rue Montoyer 51, 1000 Brussels. Under this agreement H+K provided ESE with advice related to health and research policies. This advice related to the legislative proposals of interest, and related to communication . -
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
1. European Hormone Day 'Because Hormones Matter' - Building Public and Policy Awareness for the Role of Hormones in Public Health - 15 May 2023.
2. Response to consultations in the field of the policies listed above.
(CLP Regulation, BPA, European Health Data Space and others).
3. Publication of the White Paper Hormones in European Health Policies, How Endocrinologist can contribute towards a healthier Europe (May 2021).
4. Publication of 'the Milano Declaration' Recognising the Key Role of Hormones European Health (May 2022).
5. Publication of 'Ten recommendations for Good Hormone Health' Annex of the Milano Declaration (May 2023).
6. Participation and support to the event 'Shaping an ambitious legislative framework for Endocrine Disruptors' - a high level panel discussion on the gaps between science and legislation' - (European Parliament - Brussels) - June 2023
7. Participation to the Annual European Commission Endocrine Disruptors Forum (Brussels, October 2023).
8. Engagement with European Commission related to the REACH Legislative Proposal (March 2023).Other activities
None declared
Meetings
Meetings
None declared